Browsing Tag
renal disease
3 posts
Why complement pathway competition in renal disease is intensifying around oral C5aR therapies
InflaRx N.V. is expanding izicopan across renal diseases as complement therapy competition intensifies. Discover what this means for nephrology markets.
Telitacicept delivers breakthrough proteinuria decline in Chinese IgA nephropathy phase 3 study
Find out how RemeGen’s Telitacicept achieved phase 3 success in reducing proteinuria for IgA nephropathy patients in China.
Fresenius Medical Care sells laboratory assets to Quest Diagnostics in strategic portfolio shift
Fresenius Medical Care has announced the sale of select laboratory assets to Quest Diagnostics as part of a…